Creative Planning Bluebird Bio, Inc. Transaction History

Creative Planning

$101 Billion
Q3 2024

A detailed history of Creative Planning transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Creative Planning holds 23,350 shares of BLUE stock, worth $7,005. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,350

Holding current value

$7,005

% of portfolio

0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	BUY	$0.47 - $1.35 $10,974 - $31,522	23,350 New	23,350 $12,000
Q2 2021 Aug 04, 2021	SELL	$18.04 - $22.09 $168,313 - $206,099	-9,330 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$16.59 - $33.89 $154,784 - $316,193	9,330 New	9,330 $281,000
Q1 2020 May 05, 2020	SELL	$26.16 - $63.5 $808,187 - $1.96 Million	-30,894 Closed	0 $0
Q4 2019 Jan 30, 2020	BUY	$46.96 - $61.67 $1.45 Million - $1.91 Million	30,894 New	30,894 $2.71 Million
Q2 2019 Jul 26, 2019	SELL	$75.84 - $105.21 $379,200 - $526,050	-5,000 Closed	0 $0
Q1 2019 Apr 24, 2019	SELL	$64.44 - $104.11 $13,919 - $22,487	-216 Reduced 4.14%	5,000 $787,000
Q4 2018 Feb 01, 2019	BUY	$59.1 - $93.26 $151,296 - $238,745	2,560 Added 96.39%	5,216 $517,000
Q3 2018 Oct 25, 2018	BUY	$88.86 - $117.49 $20,526 - $27,140	231 Added 9.53%	2,656 $388,000
Q2 2018 Jul 20, 2018	BUY	$99.64 - $127.59 $241,627 - $309,405	2,425 New	2,425 $381,000
Q1 2018 Apr 18, 2018	SELL	$105.8 - $150.94 $192,132 - $274,107	-1,816 Closed	0 $0
Q4 2017 Jan 17, 2018	BUY	$81.25 - $130.7 $147,550 - $237,351	1,816	1,816 $323,000

Others Institutions Holding BLUE

# of Institutions

151

Shares Held

63.4M

Call Options Held

264K

Put Options Held

428K

Black Rock Inc. New York, NY

15.4M
Shares

$4.63 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

10.5M
Shares

$3.14 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

4.68M
Shares

$1.4 Million
0.0% of portfolio
Pictet Asset Management Sa Geneva 73, V8

4.67M
Shares

$1.4 Million
0.02% of portfolio
State Street Corp Boston, MA

3.84M
Shares

$1.15 Million
0.0% of portfolio

View Full List

About bluebird bio, Inc.

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $23.1M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

More about BLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account